Skip to main content

Advertisement

Table 2 Treatment characteristics

From: The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy

Characteristic n (%)
Radiotherapy   
  3D-CRT 142 (90)
    Median 63 Gy   
    (59.5–74 Gy/25–37 fractions)   
  Tomotherapy 12 (8)
    Median 66 Gy   
    (66–70.4 Gy/27–35 fractions)   
  IMRT 3 (2)
    60 Gy   
    (60 Gy/25–30 fractions)   
Chemotherapy   
  Cisplatin, Etoposide 54 (34)
  Carboplatin, Paclitaxel 50 (32)
  Cisplatin, Paclitaxel 36 (23)
  Cisplatin, Irinotecan 17 (11)
  1. Abbreviations: 3D-CRT Three-dimensional radiotherapy, IMRT Intensity-modulated radiotherapy.